Works matching IS 02724391 AND DT 2023 AND VI 84 AND IP 1

Results: 11

Evaluation of geranylgeranyl diphosphate synthase inhibition as a novel strategy for the treatment of osteosarcoma and Ewing sarcoma.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 62, doi. 10.1002/ddr.22012
By:
- Haney, Staci L.;
- Feng, Dan;
- Chhonker, Yashpal S.;
- Varney, Michelle L.;
- Williams, Jacob T.;
- Smith, Lynette M.;
- Ford, James B.;
- Murry, Daryl J.;
- Holstein, Sarah A.
Publication type:
Article
Discovery of pyrazole‐carbohydrazide with indole moiety as tubulin polymerization inhibitors and anti‐tumor candidates.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 110, doi. 10.1002/ddr.22016
By:
- Man, Ruo‐Jun;
- Lu, Tian;
- Zheng, Chi‐Chong;
- Li, Tong;
- Wu, Meng‐Ke;
- Li, Dong‐Dong;
- He, Xue‐Mei
Publication type:
Article
Expanding the therapeutic options for Candida infections using novel inhibitors of secreted aspartyl proteases.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 96, doi. 10.1002/ddr.22015
By:
- Chakraborty, Shuvechha;
- Rahate, Kshitija;
- Kumar, Chandan;
- Idicula‐Thomas, Susan
Publication type:
Article
Labdane conjugates protect cardiomyocytes from doxorubicin‐induced cardiotoxicity.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 84, doi. 10.1002/ddr.22014
By:
- Cuadrado, Irene;
- Oramas‐Royo, Sandra;
- González‐Cofrade, Laura;
- Amesty, Ángel;
- Hortelano, Sonsoles;
- Estévez‐Braun, Ana;
- de las Heras, Beatriz
Publication type:
Article
Differential effects of proton pump inhibitors and vonoprazan on vascular endothelial growth factor expression in cancer cells.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 75, doi. 10.1002/ddr.22013
By:
- Ando‐Matsuoka, Rie;
- Yagi, Kenta;
- Takaoka, Mayu;
- Sakajiri, Yuko;
- Shibata, Tomokazu;
- Sawada, Ryusuke;
- Maruo, Akinori;
- Miyata, Koji;
- Aizawa, Fuka;
- Hamano, Hirofumi;
- Niimura, Takahiro;
- Izawa‐Ishizawa, Yuki;
- Goda, Mitsuhiro;
- Sakaguchi, Satoshi;
- Zamami, Yoshito;
- Yamanishi, Yoshihiro;
- Ishizawa, Keisuke
Publication type:
Article
Multitargeted C9‐substituted ester and ether derivatives of berberrubine for Alzheimer's disease: Design, synthesis, biological evaluation, metabolic stability, and pharmacokinetics.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 121, doi. 10.1002/ddr.22017
By:
- Raghuvanshi, Rinky;
- Jamwal, Ashiya;
- Nandi, Utpal;
- Bharate, Sandip B.
Publication type:
Article
Novel Vanillin‐based hybrids inhibit quorum sensing and silences phenotypical expressions in Pseudomonas aeruginosa.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 45, doi. 10.1002/ddr.22011
By:
- Dua, Tamanna;
- Mangal, Surabhi;
- Akshita, Goel;
- Harshdeep;
- Atri, Ankit K.;
- Sharma, Purshotam;
- Harjai, Kusum;
- Singh, Vasundhara
Publication type:
Article
Ulinastatin ameliorates the malignant progression of prostate cancer cells by blocking the RhoA/ROCK/NLRP3 pathway.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 36, doi. 10.1002/ddr.22010
By:
- Liu, Zhiguang;
- Zhu, Xiaochun;
- Xu, Chenglin;
- Min, Feng;
- Yu, Guofeng;
- Chen, Chuhong
Publication type:
Article
Dioscin induces osteosarcoma cell apoptosis by upregulating ROS‐mediated P38 MAPK signaling.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 25, doi. 10.1002/ddr.22009
By:
- Zheng, Gui‐zhou;
- Zhang, Qi‐hao;
- Chang, Bo;
- Xie, Peng;
- Liao, Hang;
- Du, Shi‐xin;
- Li, Xue‐dong
Publication type:
Article
In vitro enzymatic evaluation of some pyrazolo[1,5‐a]pyrimidine derivatives: Design, synthesis, antioxidant, anti‐diabetic, anti‐Alzheimer, and anti‐arthritic activities with molecular modeling simulation.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 3, doi. 10.1002/ddr.22008
By:
- Hassan, Ashraf S.;
- Morsy, Nesrin M.;
- Aboulthana, Wael M.;
- Ragab, Ahmed
Publication type:
Article
Issue Information.
Published in:
Drug Development Research, 2023, v. 84, n. 1, p. 1, doi. 10.1002/ddr.21943
Publication type:
Article